Recap: Humana Q1 Earnings

 

Shares of Humana HUM were flatin pre-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share rose 42.04% year over year to $7.67, which beat the estimate of $7.07.

Revenue of $20,753,000,000 higher by 9.60% from the same period last year, which beat the estimate of $20,520,000,000.

Outlook

The upcoming fiscal year's EPS expected to be between $21.25 and $21.75.

Details Of The Call

Date: Apr 28, 2021

Time: 09:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/u3q922mt

Technicals

Company's 52-week high was at $474.70

52-week low: $359.46

Price action over last quarter: Up 16.54%

Company Profile

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services and pharmacy benefit management.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!